Polymorphisms in Human Muscarinic Receptor Subtype GenesMICHEL, Martin C; TEITSMA, Christine A.Handbook of experimental pharmacology. 2012, Vol 208, pp 49-59, issn 0171-2004, 11 p.Article

Overview of Muscarinic Receptor SubtypesEGLEN, Richard M.Handbook of experimental pharmacology. 2012, Vol 208, pp 3-28, issn 0171-2004, 26 p.Article

Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypesLEE, N. H; EL-FAKAHANY, E. E.The Journal of pharmacology and experimental therapeutics. 1991, Vol 256, Num 2, pp 468-479, issn 0022-3565, 12 p.Article

Two types of neuronal muscarine receptors modulating acetylcholine release from guinea-pig myenteric plexusKILBINGER, H; NAFZIGER, M.Naunyn-Schmiedeberg's archives of pharmacology. 1985, Vol 328, Num 3, pp 304-309, issn 0028-1298Article

Muscarinic Receptor Agonists and Antagonists: Effects on Cardiovascular FunctionHARVEY, Robert D.Handbook of experimental pharmacology. 2012, Vol 208, pp 299-316, issn 0171-2004, 18 p.Article

An HPLC method for determination of atropine in human plasmaSHAOYOUG LI; WAHBA KHALIL, S. K.Journal of liquid chromatography. 1990, Vol 13, Num 7, pp 1339-1350, issn 0148-3919Article

Muscarinic receptors and receptor-mediated actions on rat thymocytesMASLINSKI, W; KULLBERG, M; NORDSTROM, O et al.Journal of neuroimmunology. 1988, Vol 17, Num 4, pp 265-274, issn 0165-5728Article

Studies on muscarinic binding sites in human brain identified with [³H]pirenzepineSIONG-CHI LIN; OLSON, K. C; OKAZAKI, H et al.Journal of neurochemistry. 1986, Vol 46, Num 1, pp 274-279, issn 0022-3042Article

Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM₁ muscarinic acetylcholine receptorMELANCON, Bruce J; GOGLIOTTI, Rocco D; MORRISON, Ryan D et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 10, pp 3467-3472, issn 0960-894X, 6 p.Article

Development of novel M₁ antagonist scaffolds through the continued optimization of the MLPCN probe ML012MELANCON, Bruce J; UTLEY, Thomas J; JEFFREY CONN, P et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 15, pp 5035-5040, issn 0960-894X, 6 p.Article

Long-term wash-resistant effects of brief interaction of xanomeline at the M₁ muscarinic receptorDE LORME, Kayla C; SIKORSKI, Krista L; GRANT, Marianne K. O et al.Neuroscience letters. 2006, Vol 410, Num 1, pp 11-14, issn 0304-3940, 4 p.Article

Conformational analysis and receptor modelling of m1 and m2 selective antagonistsKERCKHOFF, H; HÖLTJE, H.-D.Pharmazie. 1994, Vol 49, Num 8, pp 566-573, issn 0031-7144Article

Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptorBARBIER, P; COLELLI, A; BOLOGNESI, M. L et al.European journal of pharmacology. 1998, Vol 355, Num 2-3, pp 267-274, issn 0014-2999Article

Muscarinic receptor heterogeneity revealed by interaction with bretylium tosylate: different ligand-receptor conformations versus different receptor subclassesSCHREIBER, G; SOKOLOVSKY, M.Molecular pharmacology. 1985, Vol 27, Num 1, pp 27-31, issn 0026-895XArticle

Structural correlates for down-regulation of m1 and m2 muscarinic receptor subtypesMALATYNSKA, E; WAITE, S; WEI, H.-B et al.Brain research bulletin. 1998, Vol 47, Num 3, pp 285-290, issn 0361-9230Article

Otenzepad shows two populations of binding sites in human gastric smooth muscleBELLIDO, I; FERNANDEZ, J. L; GOMEZ, A et al.Canadian journal of physiology and pharmacology. 1995, Vol 73, Num 1, pp 124-129, issn 0008-4212Article

Differential selectivity of M1 and M3 type muscarinic acetylcholine receptors in coupling with a G protein Go1α examined in Xenopus oocytesFUJII, K; KASAHARA, J; NAKAMURA, K et al.Neuroscience letters. 1996, Vol 215, Num 2, pp 131-133, issn 0304-3940Article

Pharmacological basis for functional selectivity of partial muscarinic receptor agonistsHELDMAN, E; BARG, J; FISHER, A et al.European journal of pharmacology. 1996, Vol 297, Num 3, pp 283-291, issn 0014-2999Article

Stereoselectivity of (R)- and (S)-hexahydro-difenidol binding to neuroblastoma M₁, cardiac M₂, pancreatic M₃, and striatum M₄ muscarinic receptorsWAELBROECK, M; CAMUS, J; TASTENOY, M et al.Chirality (New-York, NY). 1991, Vol 3, Num 2, pp 118-123, issn 0899-0042, 6 p.Article

The effects of the tramadol metabolite O-desmethyl tramadol on muscarinic receptor-induced responses in Xenopus oocytes expressing cloned M₁ or M₃ receptorsNAKAMURA, Motohiro; MINAMI, Kouichiro; UEZONO, Yasuhito et al.Anesthesia and analgesia. 2005, Vol 101, Num 1, pp 180-186, issn 0003-2999, 7 p.Article

Role of M₂, M₃, and M₄ muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in ratsCAI, You-Qing; CHEN, Shao-Rui; HAN, Hee-Dong et al.Journal of neurochemistry. 2009, Vol 111, Num 4, pp 1000-1010, issn 0022-3042, 11 p.Article

Variation of M₃ muscarinic receptor expression in different prostate tissues and its significanceWEI SONG; MINGZHEN YUAN; SHENGTIAN ZHAO et al.Saudi medical journal. 2009, Vol 30, Num 8, pp 1010-1016, issn 0379-5284, 7 p.Article

Synthesis and antimuscarinic activity of 2-[N-(ethyl)-(N,β-hydroxyethyl)]aminoethyl 2,2-diphenylpropionate, a metabolite of aprophenBROWN, N. D; LEADER, H; PHILLIPS, L. R et al.Journal of pharmaceutical sciences. 1993, Vol 82, Num 6, pp 563-564, issn 0022-3549Article

Isolation of the human ml (Hml) muscarinic acetylcholine receptor gene by PCR amplificationCHAPMAN, C. G; BROWNE, M. J.Nucleic acids research. 1990, Vol 18, Num 8, pp 2191-2191, issn 0305-1048, 1 p.Article

Different agonist binding properties of M1 and M2 muscarinic receptors in calf brain cortex membranesVANDERHEYDEN, P; EBINGER, G; VAUQUELIN, G et al.Biochemical pharmacology. 1987, Vol 36, Num 23, pp 4119-4124, issn 0006-2952Article